Immunotherapy biomarkers are sought for the good, the bad and the ugly – BioWorld Online
|
Immunotherapy biomarkers are sought for the good, the bad and the ugly
BioWorld Online CHICAGO – At the 2017 annual meeting of the American Society of Clinical Oncology (ASCO), immunotherapy was front and center, as it is wont to be these days. "This whole meeting, you're going to hear about immunotherapy, Roy Herbst, chief of medical … |
